Page last updated: 2024-10-30

letrozole and Aberrant Tissue

letrozole has been researched along with Aberrant Tissue in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Endometriosis was induced surgically in the following groups of mice: 1) untreated transgenic mice with disrupted P450arom gene (ArKO); 2) ArKO mice treated with systemic estrogen; 3) untreated wild-type (WT) mice; 4) WT mice treated with estrogen; 5) WT mice treated with the aromatase inhibitor, letrozole; and 6) WT mice treated with letrozole and estrogen."1.31Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue. ( Bulun, SE; Evans, D; Fang, Z; Gurates, B; Simpson, E; Tamura, M; Yang, S, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rajan, S1
Munot, K1
Haselden, J1
Fang, Z1
Yang, S1
Gurates, B1
Tamura, M1
Simpson, E1
Evans, D1
Bulun, SE1

Other Studies

2 other studies available for letrozole and Aberrant Tissue

ArticleYear
Breast cancer associated with an accessory nipple.
    BMJ case reports, 2011, Jul-28, Volume: 2011

    Topics: Aged, 80 and over; Aromatase Inhibitors; Biopsy, Large-Core Needle; Breast Neoplasms; Choristoma; Fe

2011
Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:7

    Topics: Animals; Aromatase; Aromatase Inhibitors; Cell Division; Choristoma; Endometriosis; Enzyme Inhibitor

2002